← Open Payments lookup

MICHAEL KOLODGIE: Open Payments

NPI 1841852357 · NEW CASTLE, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$774 in 36 payments from 10 companies in 2025. Trend: 2023 $991 · 2024 $840 · 2025 $774

Food & beverage: $774
CompanyPaymentsAmount
Axsome Therapeutics, Inc.11$222
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$162
Lundbeck LLC4$92
E.R. Squibb & Sons, L.L.C.4$90
Vanda Pharmaceuticals Inc.2$65
Alkermes, Inc.2$48
Janssen Pharmaceuticals, Inc2$38
Otsuka America Pharmaceutical, Inc.1$23
Neurocrine BioSciences, Inc.1$17
Braeburn Inc.1$17

Products named: Auvelity, CAPLYTA, REXULTI, COBENFY, INVEGA SUSTENNA, FANAPT, HETLIOZ, ARISTADA.

Industry payments across DE — which companies pay providers there.